AssetMark Inc’s iShares US Pharmaceuticals ETF IHE Stock Holding History

AssetMark Inc’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$58.2K	Hold	579	–	–	﹤0.01%	1822
2026 Q2	$57.3K	Buy	579 +114	+25%	+$10.3K	﹤0.01%	1788
2026 Q1	$40.3K	Hold	465	–	–	﹤0.01%	1824
2025 Q4	$39.4K	Buy	465 +312	+204%	+$24.9K	﹤0.01%	1794
2025 Q3	$11.1K	Sell	153 -153	-50%	-$10.6K	﹤0.01%	2092
2025 Q2	$20.1K	Sell	306 -126	-29%	-$8.2K	﹤0.01%	1806
2025 Q1	$30.5K	Hold	432	–	–	﹤0.01%	1581
2024 Q4	$28.4K	Hold	432	–	–	﹤0.01%	1571
2024 Q3	$30.5K	Buy	432 +216	+100%	+$15.1K	﹤0.01%	1404
2024 Q2	$14.3K	Buy	+216	New	+$14.2K	﹤0.01%	1440
2023 Q4	–	Sell	-102	Closed	-$6.02K	–	1929
2023 Q3	$6.02K	Buy	+102	New	+$6.26K	﹤0.01%	1369
2017 Q2	–	Sell	-48	Closed	-$2K	–	1432
2017 Q1	$2K	Buy	+48	New	+$2.38K	﹤0.01%	1135

Other funds holding IHE

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $7.73B AUM 29.41% 1-Year Est. Return

McElhenny Sheffield Capital Management Dallas, Texas $431M AUM 6.99% 1-Year Est. Return

Arkansas Financial Group Little Rock, Arkansas $751M AUM 9.21% 1-Year Est. Return

Well Done LLC Holland, Michigan $732M AUM 14.62% 1-Year Est. Return

Virtue Capital Management Brentwood, Tennessee $768M AUM 30.82% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.21B AUM 14.38% 1-Year Est. Return

AssetMark Inc's IHE Position: Q3 2026 in Review

AssetMark Inc held its iShares US Pharmaceuticals ETF (IHE) position steady in Q3 2026 at 579 shares worth $58.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

AssetMark Inc first reported a position in IHE in Q1 2017 and has held it in 12 quarters since. 126 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

AssetMark Inc held 579 shares of iShares US Pharmaceuticals ETF worth $58.2K as of Q3 2026.
AssetMark Inc left its iShares US Pharmaceuticals ETF share count unchanged in Q3 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1822 holding.
AssetMark Inc first reported a position in iShares US Pharmaceuticals ETF in Q1 2017 and has held it in 12 quarters since.
126 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.